These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4858808)

  • 1. Effect of barbital on cerebral cortical respiration of barbital-tolerant rats.
    Roth-Schechter BF
    Biochem Pharmacol; 1974 May; 23(10):1545-8. PubMed ID: 4858808
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in behavior, EEG, and brain cortical GABA content following prolonged administration and subsequent withdrawal of barbital in the rat.
    Blagoeva P; Longo VG; Masi I; De Carolis AS
    Behav Biol; 1972 Oct; 7(5):755-60. PubMed ID: 4672852
    [No Abstract]   [Full Text] [Related]  

  • 3. [3H]muscimol and [3H]quinuclidinyl benzilate binding in rat cortex in the abstinence after long-term barbital treatment.
    Nordberg A; Wahlström G; Eriksson B
    Acta Physiol Scand; 1986 Jan; 126(1):153-6. PubMed ID: 3006433
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of barbital and lorazepam in the AT and ANT rats: motor performance and brain monoamine functions.
    Hellevuo K; Kiianmaa K; Juhakoski A
    Alcohol Alcohol Suppl; 1987; 1():647-51. PubMed ID: 2447906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 9. Increases in neuronal Ca2+ flux after withdrawal from chronic barbiturate treatment.
    Rabbani M; Little HJ
    Eur J Pharmacol; 1999 Jan; 364(2-3):221-7. PubMed ID: 9932727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated withdrawal from barbital as a drive for 'drug taking behavior' in rats.
    Jänicke UA; Coper H
    Drug Alcohol Depend; 1984 Jan; 13(1):43-54. PubMed ID: 6539666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic administration and withdrawal of sodium barbitone on protein synthesis of rat brain.
    Leite JR; Arnaiz GR
    Pharmacol Biochem Behav; 1978 Apr; 8(4):323-6. PubMed ID: 566928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenergic supersensitivity in the rat vas deferens during barbital withdrawal.
    Saban R; De Moraes S
    Eur J Pharmacol; 1977 May; 43(2):195-8. PubMed ID: 559576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep patterns in cats during chronic low-dose barbiturate treatment and withdrawal.
    Hinman DJ; Okamoto M
    Sleep; 1984; 7(1):69-76. PubMed ID: 6538986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation of potassium-stimulated respiration in rat cerebral cortical slices.
    Holtzman D; Olson J; Zamvil S; Nguyen H
    J Neurochem; 1982 Jul; 39(1):274-6. PubMed ID: 7086416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in brain gamma-aminobutyric acid and in barbital narcosis during ethanol withdrawal.
    Patel GJ; Lal H
    J Pharmacol Exp Ther; 1973 Sep; 186(3):625-9. PubMed ID: 4738015
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of alpha-methyl-p-tyrosine on the incidence of spontaneous convulsions observed following barbital withdrawal.
    Morgan WW; Pfeil KA; Gonzales EG
    Neuropharmacology; 1978 Feb; 17(2):115-9. PubMed ID: 565016
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.